Y-90: The Complete Course

Y-90: The Complete Course
February 6-9, 2014
Fairmont Scottsdale Princess
Scottsdale, Arizona

Registration for 2014 Y-90: The Complete Course is now closed.

  • Two premier learning opportunities combined — This is the only educational opportunity dedicated to Authorized User and Advanced practice of Y-90 treatment of hepatic malignancies.
  • The most comprehensive and challenging radioembolization learning experience available to interventional radiologists and trainees.

Corporate supporter? Exhibitor? Learn more.

Online Registration

Registration Now Open.

Y-90: The Complete Course -- Need to Know

  • Not yet an Authorized User? This is an ideal opportunity to fulfill some of the requirements to qualify to apply for Authorized User (AU) status to ensure you are providing your patients the very best in oncologic and clinical care.
  • Already an experienced Authorized User? The Advanced portion of the course (available as a stand-alone opportunity) will help you strengthen and grow your practice.
  • Hone radioembolization techniques, learn about current algorithms and outcomes and benefit from a summary of the latest in Y-90 literature.
  • If you are considering a focus in IO (one of the fastest-growing area in interventional radiology), Y-90: The Complete Course will provide practical insights and essentials to get you started.
  • For information contact Ashley Cole, (703) 460-5588.

Program and Brochure

View the Y90 program and brochure.

Program Coordinators

Matthew S. Johnson, M.D., FSIR
Indiana University School of Medicine
Carmel, Ind.

Robert J. Lewandowski, M.D., FSIR
Northwestern Memorial Hospital

Daniel Sze, M.D., PhD, FSIR
Stanford University Medical Center
Stanford, Calif.

Course Description

This three-day course, designed with lectures, panel discussions, case scenarios and hands-on workshops, will offer the most in-depth, comprehensive and challenging curriculum available for clinical teams interested in initiating, developing, or strengthening their practice in this exciting aspect of interventional oncology. Pre-course web lectures and the one-day Authorized User (AU) part of this course incorporate the requisite training and testing for official SIR validation of the IR attendee as qualified to apply for AU status for intra-arterial Y-90 in the treatment of hepatic malignancies. The following two-day Advanced Y-90 portion of the course is open to both the AU participants and also more experienced users as a standalone course that will present more complex topics, including challenging anatomy, therapy for specific primary and secondary hepatic malignancies—including radioembolization in combination with other therapies, retreatment, post-procedural care and follow up and management of complications.

Target Audience

Y-90: The Complete Course will provide focused educational opportunities for interventional radiologists and trainees interested in initiating, developing, or strengthening their practice in using intra-arterial Y-90 in the treatment of hepatic malignancies.

Educational Objectives

AU Educational Objectives:

Upon completion of the AU portion of this course, the attendee should be able to:

  • Compare and contrast current device platforms
  • Explore trends in patient selection and outcome prediction and discuss the relative importance of patient age, performance status, degree of cirrhosis, and cancer stage
  • Review information on the treatment algorithm, the rationale for the two-stage approach, device delivery strategies and microcatheters, coiling and embolization techniques and describe issues in post-procedural care and follow-up
  • Describe best practice in Y-90 radiation safety and dose management
  • Describe advanced radiation physics and various methods of calculation of dosimetry and how they vary between available platforms
  • Demonstrate an advanced knowledge of Y-90 administration procedure, including familiarity with both available administration systems
  • Describe responsibilities and significance of AU status in the comprehensive management of radioembolization and identify the importance of a robust radiation safety program
  • Identify state and institutional requirements for becoming an AU and demonstrate comprehension of the elements and significance of a robust radiation safety program as it relates to intra-arterial Y-90 therapy
  • Discuss appropriate follow-up and patient prognosis after radioembolization

Advanced Y-90 Educational Objectives:

Upon completion of the advanced portion of this course, the attendee should be able to:

  • Discuss the current algorithms and outcomes for treatment of primary and secondary hepatic malignancies inclusive of surgical, medical and transarterial therapies and explore the ideal sequencing of radioembolization in those algorithms
  • Demonstrate hands-on advanced microcatheterization and embolization skills pertinent device delivery
  • Describe advanced radioembolization techniques
  • Identify therapies used in combination with radioembolization for hepatic malignancy
  • Explain advanced dosimetry and treatment concepts
  • Summarize a state-of-the-art literature review of Y-90 radioembolization


Aravind Arepally, MD, FSIR
Piedmont Healthcare
Atlanta, Ga.

Daniel B. Brown, MD, FSIR
Vanderbilt University Medical Center
Nashville, Tenn.

Constantinos T. Sofocleous, MD, PhD, FSIR
Memorial Sloan-Kettering Cancer Center
New York, NY

Edward Kim, MD
Mt. Sinai Medical Center
New York, N.Y.

Charles E. Ray Jr., MD, PhD, FSIR
University of Colorado Denver
Aurora, Colo.

Mack Richard, CHP
Indiana University Medical Center
Indianapolis, Ind.

William S. Rilling, MD, FSIR
Medical College of Wisconsin
Milwaukee, Wisc.

Riad Salem, MD, MBA, FSIR
Northwestern Memorial Hospital
Chicago, Ill.

Accreditation and CME Information

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME). The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide medical education for physicians.

The Society of Interventional Radiology designates this live activity for a maximum of 21.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program will be approved for self-assessment module (SAM) credit by the Society of Interventional Radiology (SIR). SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SAMs offered at this live meeting meet the ABR's criteria for a self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program. More information about SAM approval will be available soon.


Supporter information will be available soon.

Hotel Information

Fairmont Scottsdale Princess
7575 East Princess Drive
Scottsdale, Arizona

For hotel reservations, please call 1-800-344-4758 and reference the SIR Y90 Oncology Meeting. The room rate is $249 per night. The hotel reservation deadline is January 5, 2014.

SIR Policies

SIR Participation Policy

Society of Interventional Radiology staff, members, nonmembers and event participants must be treated with respect in all interactions (including but not limited to in-person, telephone or via written communications). All agree to conduct themselves in a manner appropriate for health care professionals. Staff offices and the press room at meeting sites are reserved for official business only; food and beverage service in these areas are reserved for staff and volunteer members. If a staff member believes that these rules have been violated or acceptable social decorum has otherwise been breached, the staff member shall contact one of the designated individuals in the volunteer leadership to help with the situation. If the member in question believes that he/she has been wrongly accused of inappropriate behavior, he/she shall also contact the designated physician leadership to help with the situation.

SIR Photo Disclaimer

Registration and attendance at, or participation in, the Society of Interventional Radiology's meetings and other activities constitute an agreement by the registrant/attendee to SIR's use and distribution (both now and in the future) of the registrant's or attendee's image or voice in photographs, videotapes, electronic reproductions and audio tapes ("images/recordings") of such events and activities. Registrant/attendee acknowledges and agrees that SIR's use or distribution of such images/recordings may be worldwide and in any medium; that SIR may identify registrants or attendees in such images or recordings; and that registrants/attendees have no right to any compensation for such uses.